29min chapter

The Proof with Simon Hill cover image

New heart disease test you should order | Thomas Dayspring, Md

The Proof with Simon Hill

CHAPTER

Advancements in Heart Disease Medications

This chapter explores the development of drugs targeting heart disease, specifically CETP inhibitors and their effects on major adverse cardiovascular events and lipoprotein(a) levels. It highlights promising treatments like anisetropib and obisetropib, while also discussing the complexities of drug regulation and the need for extensive research. The conversation emphasizes the significance of lifestyle changes and traditional therapies like aspirin in managing cardiovascular risks associated with elevated lipoprotein(a).

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode